Author:
Medeiros B C,Landau H J,Morrow M,Lockerbie R O,Pitts T,Eckhardt S G
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference32 articles.
1. Cortes JE, Kurzrock R, Kantarjian HM . Future clinical implications for farnesyl transferase inhibitors in hematologic malignancies. Semin Hematol 2003; 39: 26–30.
2. Hiddemann W, Kern W, Schoch, Fonatsch C, Heinecke A, Wormann B et al. Management of acute myeloid leukemia in elderly patients. J Clin Oncol 1999; 17: 3569–3576.
3. Baer MR, George SL, Dodge RK, O'Loughlin KL, Minderman H, Caligiuri MA et al. Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720. Blood 2002; 100: 1224–1232.
4. Leith C, Kopecky KJ, Godwin J . Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A southwest oncology group study. Blood 1997; 189: 3323–3329.
5. Dastugue N, Payen C, Lafage-Pochitaloff M, Bernard P, Leroux D, Huguet-Rigal F et al. Prognostic significance of kayrotype in de novo adult acute myeloid leukemia. Leukemia 1995; 9: 1491–1498.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献